tiprankstipranks
Trending News
More News >
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market
Advertisement

Spyre Therapeutics (SYRE) Technical Analysis

Compare
471 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Spyre Therapeutics’s (SYRE) Moving Averages Convergence Divergence (MACD) indicator is -0.16, suggesting Spyre Therapeutics is a Sell.
Spyre Therapeutics’s (SYRE) 20-Day exponential moving average is 15.97, while Spyre Therapeutics’s (SYRE) share price is $16.24, making it a Buy.
Spyre Therapeutics’s (SYRE) 50-Day exponential moving average is 16.15, while Spyre Therapeutics’s (SYRE) share price is $16.24, making it a Buy.

Spyre Therapeutics (SYRE) Pivot Points

Sep 28, 2025, 12:19 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.67
14.62
15.11
16.06
16.55
17.50
17.99
Fibonacci
14.62
15.17
15.51
16.06
16.61
16.95
17.50
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Spyre Therapeutics (SYRE) Moving Averages

Sep 28, 2025, 12:19 AM
Period
Simple
Exponential
MA5
16.03Buy
15.99Buy
MA10
15.51Buy
15.88Buy
MA20
16.02Buy
15.97Buy
MA50
16.40Sell
16.15Buy
MA100
15.98Buy
16.64Sell
MA200
17.82Sell
19.44Sell
Spyre Therapeutics’s (SYRE) 10-Day exponential moving average is 15.88, while Spyre Therapeutics’s (SYRE) share price is $16.24, making it a Buy.
Spyre Therapeutics’s (SYRE) 100-Day exponential moving average is 16.64, while Spyre Therapeutics’s (SYRE) share price is $16.24, making it a Sell.
Spyre Therapeutics’s (SYRE) stock price is $16.24 and Spyre Therapeutics’s (SYRE) 50-day simple moving average is 16.40, creating a Sell signal.
Spyre Therapeutics’s (SYRE) stock price is $16.24 and Spyre Therapeutics’s (SYRE) 100-day simple moving average is 15.98, creating a Buy signal.
Spyre Therapeutics’s (SYRE) stock price is $16.24 and Spyre Therapeutics’s (SYRE) 200-day simple moving average is 17.82, creating a Sell signal.

Spyre Therapeutics (SYRE) Technical Indicators

Sep 28, 2025, 12:19 AM
Name
Value
Implied Action
RSI (14)
51.45
Neutral
STOCH (9,6)
68.01
Neutral
STOCHRSI (14)
63.19
Neutral
MACD (12,26)
-0.16
Sell
ADX (14)
14.64
Buy
Williams %R
-33.65
Buy
CCI (14)
19.08
Neutral
ATR (14)
0.90
-
Ultimate Oscillator
52.51
Neutral
ROC
-2.35
Sell
Spyre Therapeutics’s (SYRE) Relative Strength Index (RSI) is 51.45, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Trend Strength Indicator (ADX) is 14.64, creating a Buy signal.
Spyre Therapeutics’s (SYRE) Commodity Channel Index (CCI) is 19.08, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Price Rate of Change (ROC) is -2.35, creating a Sell signal.

FAQ

Is SYRE a Buy, Hold, or Sell?
Based on SYRE’s technical indicators, SYRE is a Buy.
    What is SYRE’s RSI (14)?
    SYRE’s RSI (14) is 51.45, which suggests SYRE is a Neutral.
      What is SYRE’s MACD?
      SYRE’s MACD is -0.16, which suggests SYRE is a Sell.
        What is SYRE’s 5-day moving average?
        SYRE’s 5-day moving average is 16.03, which suggests SYRE is a Buy.
          What is SYRE’s 20-day moving average?
          SYRE 20-day moving average is 16.02, which suggests SYRE is a Buy.
            What is SYRE’s 50-day moving average?
            SYRE’s 50-day moving average is 16.40, which suggests SYRE is a Sell.
              What is SYRE’s 200-day moving average?
              SYRE’s 200-day moving average is 17.82, which suggests SYRE is a Sell.
                What is SYRE’s Williams % R (14)?
                SYRE’s Williams % R (14) is -33.65, which suggests SYRE is a Buy.
                  What is SYRE’s CCI (14)?
                  SYRE’s CCI (14) is 19.08, which suggests SYRE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis